Gastroesophageal reflux disease (GERD) is a common gastro intestinal disorder with an incidence rate of 10% - 38% of adults occurring at least once a week. The disease affects the patients’ quality of life, reduces their functional activity and predisposes them to more serious conditions as in Barretts esophagus. A complete relief from GERD can be achieved by addressing the route cause and changing life style. ELBE PHARMA offers a complete solution to GERD with MEPAX, MILAN (block acid production) and EBECID (neutralizes the acid that causes heartburn).
